David F. Mark
20Patents
14h-index
24Co-inventors
77Inventor score
Filing activity: May 5, 1982 → Mar 9, 1993
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4518584A | Human recombinant interleukin-2 muteins | Emerging Cross-Sectional Technologies | 292 | Expired |
| US4959314A | Cysteine-depleted muteins of biologically active proteins | Human Necessities | 277 | Expired |
| US4588585A | Human recombinant cysteine depleted interferon-.beta. muteins | Emerging Cross-Sectional Technologies | 246 | Expired |
| US5219727A | Quantitation of nucleic acids using the polymerase chain reaction | Chemistry; Metallurgy | 209 | Expired |
| US4737462A | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-.beta. | Emerging Cross-Sectional Technologies | 178 | Expired |
| US5476774A | Quantitation of nucleic acids using the polymerase chain reaction | Chemistry; Metallurgy | 160 | Expired |
| US5116943A | Oxidation-resistant muteins of Il-2 and other protein | Emerging Cross-Sectional Technologies | 125 | Expired |
| US4853332A | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins | Emerging Cross-Sectional Technologies | 116 | Expired |
| US4677063A | Human tumor necrosis factor | Emerging Cross-Sectional Technologies | 107 | Expired |
| US4677064A | Human tumor necrosis factor | Emerging Cross-Sectional Technologies | 95 | Expired |
| USRE33653E | Human recombinant interleukin-2 muteins | General | 54 | Expired |
| US4569908A | Multiclass hybrid interferons | Emerging Cross-Sectional Technologies | 33 | Expired |
| US4499188A | Bacterial production of heterologous polypeptides under the control of a repressible promoter-operator | Emerging Cross-Sectional Technologies | 28 | Expired |
| US4758428A | Multiclass hybrid interferons | Emerging Cross-Sectional Technologies | 24 | Expired |
| US4684623A | Use of tumor necrosis factor as a weight regulator | Emerging Cross-Sectional Technologies | 13 | Expired |
| US4939093A | Human IL-2 like polypeptides, DNA sequences and recombinant DNA molecules therefore and methods for the production and use thereof | Human Necessities | 5 | Expired |
| US4895872A | Immunosupressive analogues and derivatives of succinylacetone | Human Necessities | 4 | Expired |
| US5216005A | Immunosuppressive analogues and derivatives of succinylacetone | Human Necessities | 0 | Expired |
| US5173482A | Immunosuppressive analogues and derivatives of succinylacetone | Human Necessities | 0 | Expired |
| US5252603A | Immunosuppressive analogues and derivatives of succinylacetone | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.